Tailor V Mathes (T Mathes)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 10

Top Topics

Cerebrospinal Fluid

Regulatory T Cells

Top Venues

Nature communications

Science immunology

This page only lists publications with an associated author ORCID identifier.

Publications

Abigail R Gress, Christine E Ronayne, Joshua M Thiede, David K Meyerholz, Samuel Okurut, Julia Stumpf, Tailor V Mathes, Kenneth Ssebambulidde, David B Meya, Fiona V Cresswell, David R Boulware, Tyler D Bold
Recently activated CD4 T cells in tuberculosis express OX40 as a target for host-directed immunotherapy. Nature communications 14 (1) (2023)
Abigail R Gress, Christine E Ronayne, Joshua M Thiede, David K Meyerholz, Samuel Okurut, Julia Stumpf, Tailor V Mathes, Kenneth Ssebambulidde, David B Meya, Fiona V Cresswell, David R Boulware, Tyler D Bold
Recently activated CD4 T cells in tuberculosis express OX40 as a target for host-directed immunotherapy. Nature communications 14 (1) (2023)
Abigail R Gress, Christine E Ronayne, Joshua M Thiede, David K Meyerholz, Samuel Okurut, Julia Stumpf, Tailor V Mathes, Kenneth Ssebambulidde, David B Meya, Fiona V Cresswell, David R Boulware, Tyler D Bold
Recently activated CD4 T cells in tuberculosis express OX40 as a target for host-directed immunotherapy. Nature communications 14 (1) (2023)
Abigail R Gress, Christine E Ronayne, Joshua M Thiede, David K Meyerholz, Samuel Okurut, Julia Stumpf, Tailor V Mathes, Kenneth Ssebambulidde, David B Meya, Fiona V Cresswell, David R Boulware, Tyler D Bold
Recently activated CD4 T cells in tuberculosis express OX40 as a target for host-directed immunotherapy. Nature communications 14 (1) (2023)
Abigail R Gress, Christine E Ronayne, Joshua M Thiede, David K Meyerholz, Samuel Okurut, Julia Stumpf, Tailor V Mathes, Kenneth Ssebambulidde, David B Meya, Fiona V Cresswell, David R Boulware, Tyler D Bold
Recently activated CD4 T cells in tuberculosis express OX40 as a target for host-directed immunotherapy. Nature communications 14 (1) (2023)
Abigail R Gress, Christine E Ronayne, Joshua M Thiede, David K Meyerholz, Samuel Okurut, Julia Stumpf, Tailor V Mathes, Kenneth Ssebambulidde, David B Meya, Fiona V Cresswell, David R Boulware, Tyler D Bold
Recently activated CD4 T cells in tuberculosis express OX40 as a target for host-directed immunotherapy. Nature communications 14 (1) (2023)
Abigail R Gress, Christine E Ronayne, Joshua M Thiede, David K Meyerholz, Samuel Okurut, Julia Stumpf, Tailor V Mathes, Kenneth Ssebambulidde, David B Meya, Fiona V Cresswell, David R Boulware, Tyler D Bold
Recently activated CD4 T cells in tuberculosis express OX40 as a target for host-directed immunotherapy. Nature communications 14 (1) (2023)
Abigail R Gress, Christine E Ronayne, Joshua M Thiede, David K Meyerholz, Samuel Okurut, Julia Stumpf, Tailor V Mathes, Kenneth Ssebambulidde, David B Meya, Fiona V Cresswell, David R Boulware, Tyler D Bold
Recently activated CD4 T cells in tuberculosis express OX40 as a target for host-directed immunotherapy. Nature communications 14 (1) (2023)
Abigail R Gress, Christine E Ronayne, Joshua M Thiede, David K Meyerholz, Samuel Okurut, Julia Stumpf, Tailor V Mathes, Kenneth Ssebambulidde, David B Meya, Fiona V Cresswell, David R Boulware, Tyler D Bold
Recently activated CD4 T cells in tuberculosis express OX40 as a target for host-directed immunotherapy. Nature communications 14 (1) (2023)
Roberta Caruso, Tailor V Mathes, Eric C Martens, Nobuhiko Kamada, A Nusrat, Naohiro Inohara, Gabriel Nuñez
A specific gene-microbe interaction drives the development of Crohn's disease-like colitis in mice. Science immunology 4 (34) (2020)